MRI scans can miss epilepsy lesions that may be treatable with surgery. Dr. Konrad Wagstyl discusses how his biotech AI tools trained on large MRI datasets are helping detect subtle brain abnormalities and identify surgical candidates earlier.

Psychiatric symptoms are integral to the epilepsies and can shape disease course and quality of life. Dr. Andres M. Kanner explains how depression, anxiety, ADHD, and psychosis influence treatment decisions and outcomes.

Flash-back to our most popular episode! Epileptologist & neurologist Dr. Ángel Aledo-Serrano shares his thoughts regarding the antiseizure medication Levetiracetam/Keppra; its effectiveness and side-effects.

Who benefits from genetic testing in epilepsy, and how should uncertain results be interpreted? Christian Bosselmann discusses genome sequencing, variant interpretation, and why re-analysis over time matters.

Why routine EEGs often miss seizures – and how long-term and subcutaneous EEG monitoring can change clinical understanding of seizure burden, treatment decisions, and diagnostic certainty.

A parent-led insight into life with Dravet Syndrome, this episode explores family dynamics, caregiving roles, and findings from an ethnographic study capturing the lived experiences of families across Europe.

Prof. Nicola Specchio explores global challenges in caring for people with the epilepsies, from delayed diagnosis & inequitable access to the advances in precision medicine transforming outcomes.